SeerPharma to Deliver Online GMP and GLP Workshop for Duke-NUS CoRE

A decade ago, Duke–NUS Medical School in Singapore established the Centre of Regulatory Excellence (CoRE) to strengthen health products regulatory systems and build regulatory capability across ASEAN and the broader Asia-Pacific region. Since its inception, CoRE has played a pivotal role in supporting policy innovation and advancing the development of effective, efficient, and science-based health product regulation. As a neutral academic platform, CoRE serves as a trusted bridge between regulators, industry, and academia, fostering collaboration and developing the next generation of regional regulatory leaders within the healthcare ecosystem.

SeerPharma is proud to collaborate with Duke–NUS CoRE in the delivery of a comprehensive four-day workshop titled Good Manufacturing and Laboratory Practices for Pharmaceutical, Biotech, and Medical Device Professionals: Operational Excellence from R&D to GMP Compliance.

This in-depth training program is designed for professionals working within the pharmaceutical, biotechnology, and medical device sectors who seek to strengthen their practical understanding and operational application of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP). The workshop places a strong emphasis on the operational aspects of GMP compliance, with particular focus on the challenges organisations face when transitioning from research and development (R&D) environments to fully GMP-compliant operations.

Drawing on real-world case studies from SeerPharma’s extensive industry experience, the program combines expert-led presentations with interactive workshops and practical problem-solving exercises. Participants will gain actionable insights to support effective day-to-day operations while ensuring product quality, regulatory compliance, and sustained operational excellence across the product lifecycle.

The four-day workshop will be delivered online across two sessions:

• 24–25 March 2026 (Session 1)
• 7–8 April 2026 (Session 2)

By the conclusion of this four-day workshop, participants will be able to:

• Understand global GMP and GLP regulatory requirements, including FDA, EMA, and PIC/S standards, and apply them operationally across pharmaceutical, biotech, and medical device environments.
• Implement practical strategies to support the transition from R&D to GMP-compliant manufacturing, including scaling operations, documentation control, and quality system integration.
• Manage operational and compliance risks through risk-based decision-making, effective deviation management, and robust CAPA implementation.
• Maintain product integrity by ensuring compliance within cleanroom operations, aseptic manufacturing processes, and environmental monitoring and control systems.
• Navigate GMP compliance challenges specific to biotech and medical device manufacturing, including upstream and downstream processing, gene and advanced therapies, and materials management.
• Prepare for regulatory inspections by establishing audit readiness programs, addressing key compliance focus areas such as documentation, traceability, and CAPA, and responding effectively to inspection findings.
• Drive continuous improvement in GMP and GLP operations through the use of operational performance metrics and effective change control processes.

SeerPharma is honoured to support and contribute to the ongoing mission of Duke–NUS CoRE in advancing regulatory capability and excellence across the region.

Learn more and register for this upcoming workshop.

Download the program.

Partnering with leading academic institutions such as Duke–NUS CoRE reaffirms SeerPharma’s ongoing commitment to “Advancing Quality and GMP Best Practices across the APAC region”.